Loading provider…
Loading provider…
Hematology & Oncology Physician in Kansas City, KS
NPI: 1386806941Primary Practice Location
UNIVERSITY OF KANSAS HOSPITAL
4000 Cambridge St, Kansas City, KS
Primary Employer
University of Kansas Hospital Authority
kansashealthsystem.com
HQ Phone
Get MD Marc's Phone Numberphone_androidMobile
Get MD Marc's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
MO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 322 | 539 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 162 | 297 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 118 | 124 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 76 | 76 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 43 | 44 |
Authors: Richard Walgren, Ian Flinn, Chaitra Ujjani, Manish Patel, Jennifer Woyach, James Gerson, Donald Tsai, Nicole Lamanna, Minal Barve, Lindsey Roeker, Jennifer Kherani, Bita Fakhri, Luhua Wang, Meghan Thompson, William Wierda, Alvaro Alencar, Catherine Coombs
Journal: Haematologica
Publication Date: 2025-01-01
Immune Thrombocytopenia Purpura Secondary to COVID-19.
Authors: Bennett, Joseph, Brown, Christopher, Rouse, Michael, Hoffmann, Marc, Ye, Zhan
Journal: Cureus
Publication Date: 2020-07-09
Real-world CAR-T findings for large B-cell lymphoma from a single institution experience.
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, PROCEDURE: Computed Tomography, DRUG: Doxorubicin Hydrochloride, PROCEDURE: Lumbar Puncture
Lead Sponsor: Loxo Oncology, Inc.
Intervention / Treatment: DRUG: Pirtobrutinib
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Acalabrutinib, DRUG: Bendamustine, DRUG: Cytarabine, BIOLOGICAL: Rituximab, DRUG: Bendamustine Hydrochloride